The drug making company ‘Lupin Healthcare Limited’, which is a completely owned subsidiary of the company Lupin Limited, has announced that, followed by the approval from the United Kingdom’s Medicines and Healthcare Products Regulatory Agency (MHRA) in earlier 2021, the company has been successfully launched a new generic asthma inhaler drug known as Luforbec.
The inhaler drug Luforbec (beclomethasone/formoterol) 100/6 dose pMDI (pressurized metered dose inhaler, that is responsible in making the inhaler drug available now to the patients of asthma in the United Kingdom, along with the potential for offering the significant savings in the prices for the NHS of United Kingdom.
The inhaler drug ‘Luforbec’ has also been indicated for the treatment of the asthma disease in the adults and also fir the symptomatic treatment of the more severe chronic obstructive pulmonary disease (COPD), and the company Lupin Health Limited UK has also approved to manufacture the new inhaler drug at the different facilities of the company based in the region of Pithampur in India and in the Coral Springs region in the United States of America.
The company Lupin has always been a transnational pharmaceutical company, which is led by innovation headquartered in Mumbai, India, and the company is responsible for the development and commercialization of a wide range of the generic formulations, along with the APIs and the biotechnology products in more than 100 markets across the countries including India, the United States, Asia Pacific, South Africa, Middle-East, Latin America and Europe.
Writing is a medium to express feelings and convey facts. A creative mind never rests in peace and this amazing platform gives me the freedom to write about what I like most.
I’ve been a writer/blogger for the last twelve years and have covered technology-related topics. However, I also have considerable years of experience in writing for various domains – Technology, Beauty, Fashion, Pharmaceutical, human psychology etc. Technology is my forte.
I’ve handled many interesting projects. Writing is my passion. As an author, I’ve learned a lot in my long journey of penning down my thoughts!
